These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29163771)

  • 21. Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells.
    Daniels TR; Neacato II; Rodríguez JA; Pandha HS; Morgan R; Penichet ML
    Leukemia; 2010 Sep; 24(9):1555-65. PubMed ID: 20574452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HOX deregulation in acute myeloid leukemia.
    Rice KL; Licht JD
    J Clin Invest; 2007 Apr; 117(4):865-8. PubMed ID: 17404613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hox genes: from leukemia to hematopoietic stem cell expansion.
    Abramovich C; Pineault N; Ohta H; Humphries RK
    Ann N Y Acad Sci; 2005 Jun; 1044():109-16. PubMed ID: 15958703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.
    Feldmann F; Schenk B; Martens S; Vandenabeele P; Fulda S
    Oncotarget; 2017 Sep; 8(40):68208-68220. PubMed ID: 28978109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
    Whelan JT; Ludwig DL; Bertrand FE
    Leukemia; 2008 Jun; 22(6):1161-9. PubMed ID: 18337761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.
    Brumatti G; Ma C; Lalaoui N; Nguyen NY; Navarro M; Tanzer MC; Richmond J; Ghisi M; Salmon JM; Silke N; Pomilio G; Glaser SP; de Valle E; Gugasyan R; Gurthridge MA; Condon SM; Johnstone RW; Lock R; Salvesen G; Wei A; Vaux DL; Ekert PG; Silke J
    Sci Transl Med; 2016 May; 8(339):339ra69. PubMed ID: 27194727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
    Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
    Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Met inhibition in a HOXA9/Meis1 model of CN-AML.
    Mulgrew NM; Kettyle LM; Ramsey JM; Cull S; Smyth LJ; Mervyn DM; Bijl JJ; Thompson A
    Dev Dyn; 2014 Jan; 243(1):172-81. PubMed ID: 24307265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells.
    Spencer DH; Young MA; Lamprecht TL; Helton NM; Fulton R; O'Laughlin M; Fronick C; Magrini V; Demeter RT; Miller CA; Klco JM; Wilson RK; Ley TJ
    Leukemia; 2015 Jun; 29(6):1279-89. PubMed ID: 25600023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
    Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between the HOX gene family and the acute myeloid leukemia-review].
    Jiang Q; Liu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1340-4. PubMed ID: 24156462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cancer cell proliferation by designed peptide amphiphiles.
    Aulisa L; Forraz N; McGuckin C; Hartgerink JD
    Acta Biomater; 2009 Mar; 5(3):842-53. PubMed ID: 19249722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1.
    Krosl J; Baban S; Krosl G; Rozenfeld S; Largman C; Sauvageau G
    Oncogene; 1998 Jul; 16(26):3403-12. PubMed ID: 9692548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
    Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
    Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
    Drabkin HA; Parsy C; Ferguson K; Guilhot F; Lacotte L; Roy L; Zeng C; Baron A; Hunger SP; Varella-Garcia M; Gemmill R; Brizard F; Brizard A; Roche J
    Leukemia; 2002 Feb; 16(2):186-95. PubMed ID: 11840284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
    Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
    Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of HOXB2 and HOXB3 in acute myeloid leukemia.
    Lindblad O; Chougule RA; Moharram SA; Kabir NN; Sun J; Kazi JU; Rönnstrand L
    Biochem Biophys Res Commun; 2015 Nov; 467(4):742-7. PubMed ID: 26482852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.
    Strathdee G; Holyoake TL; Sim A; Parker A; Oscier DG; Melo JV; Meyer S; Eden T; Dickinson AM; Mountford JC; Jorgensen HG; Soutar R; Brown R
    Clin Cancer Res; 2007 Sep; 13(17):5048-55. PubMed ID: 17785556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.